SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tarig Elraiyah, Michael R. Gionfriddo, Mohammad Hassan Murad, Acting on black box warnings requires a GRADE evidence table and an implementation guide: the case of teriparatide, Journal of Clinical Epidemiology, 2015, 68, 6, 698

    CrossRef

  2. 2
    C.E. Higham, S. Faithfull, Bone Health and Pelvic Radiotherapy, Clinical Oncology, 2015,

    CrossRef

  3. 3
    Symeon Tournis, Anastasia D. Dede, Christos Savvidis, Ioannis K. Triantafyllopoulos, Antonis Kattamis, Nikolaos Papaioannou, Effects of teriparatide retreatment in a patient with β-thalassemia major, Transfusion, 2015, 55, 8
  4. 4
    Silvia Chiavistelli, Andrea Giustina, Gherardo Mazziotti, Parathyroid hormone pulsatility: physiological and clinical aspects, Bone Research, 2015, 3, 14049

    CrossRef

  5. 5
    Natalie E. Cusano, Mishaela R. Rubin, John P. Bilezikian, Parathyroid hormone therapy for hypoparathyroidism, Best Practice & Research Clinical Endocrinology & Metabolism, 2015, 29, 1, 47

    CrossRef

  6. 6
    Natalie E Cusano, Mishaela R Rubin, John P Bilezikian, PTH(1-84) replacement therapy for the treatment of hypoparathyroidism, Expert Review of Endocrinology & Metabolism, 2015, 10, 1, 5

    CrossRef

  7. 7
    Esther S. Kim, Gillian M. Keating, Recombinant Human Parathyroid Hormone (1–84): A Review in Hypoparathyroidism, Drugs, 2015, 75, 11, 1293

    CrossRef

  8. 8
    Maryam Sharifi, Lisa Ereifej, E. Michael Lewiecki, Sclerostin and skeletal health, Reviews in Endocrine and Metabolic Disorders, 2015, 16, 2, 149

    CrossRef

  9. 9
    Tamara Vokes, The Parathyroids, 2015,

    CrossRef

  10. 10
    Sundeep Khosla, The Parathyroids, 2015,

    CrossRef

  11. 11
    M. Amling, R. Oheim, F. Barvencik, A holistic hip fracture approach: individualized diagnosis and treatment after surgery, European Journal of Trauma and Emergency Surgery, 2014, 40, 3, 265

    CrossRef

  12. 12
    Sarah K. Amugongo, Wei Yao, Junjing Jia, Weiwei Dai, Yu-An E. Lay, Li Jiang, Danielle Harvey, Elizabeth A. Zimmermann, Eric Schaible, Neil Dave, Robert O. Ritchie, Donald B. Kimmel, Nancy E. Lane, Effect of sequential treatments with alendronate, parathyroid hormone (1–34) and raloxifene on cortical bone mass and strength in ovariectomized rats, Bone, 2014, 67, 257

    CrossRef

  13. 13
    Yin Tintut, Linda L. Demer, Effects of bioactive lipids and lipoproteins on bone, Trends in Endocrinology & Metabolism, 2014, 25, 2, 53

    CrossRef

  14. 14
    Tao Jiang, Xiaohua Yu, Erica J. Carbone, Clarke Nelson, Ho Man Kan, Kevin W.-H. Lo, Poly aspartic acid peptide-linked PLGA based nanoscale particles: Potential for bone-targeting drug delivery applications, International Journal of Pharmaceutics, 2014, 475, 1-2, 547

    CrossRef

  15. 15
    Abhishek Chandra, Tiao Lin, Mary Beth Tribble, Ji Zhu, Allison R. Altman, Wei-Ju Tseng, Yejia Zhang, Sunday O. Akintoye, Keith Cengel, X. Sherry Liu, Ling Qin, PTH1–34 alleviates radiotherapy-induced local bone loss by improving osteoblast and osteocyte survival, Bone, 2014, 67, 33

    CrossRef

  16. 16
    Xin Li, Jamie Garcia, Jinxiu Lu, Sidney Iriana, Ivo Kalajzic, David Rowe, Linda L. Demer, Yin Tintut, Roles of Parathyroid Hormone (PTH) Receptor and Reactive Oxygen Species in Hyperlipidemia-Induced PTH Resistance in Preosteoblasts, Journal of Cellular Biochemistry, 2014, 115, 1
  17. 17
    U. C. Bang, L. Hyldstrup, J. E. B. Jensen, The impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers, Osteoporosis International, 2014, 25, 2, 639

    CrossRef

  18. 18
    Mara J Horwitz, Marilyn Augustine, Leila Kahn, Emily Martin, Christine C Oakley, Raquel M Carneiro, Mary Beth Tedesco, Angela Laslavic, Susan M Sereika, Alessandro Bisello, Adolfo Garcia-Ocaña, Caren M Gundberg, Jane A Cauley, Andrew F Stewart, A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: The PrOP study, Journal of Bone and Mineral Research, 2013, 28, 11
  19. 19
    Cristiana Cipriani, Dinaz Irani, John P Bilezikian, Erratum: Safety of osteoanabolic therapy: A decade of experience, Journal of Bone and Mineral Research, 2013, 28, 2
  20. 20
    BARBARA C. SILVA, ALINE G. COSTA, NATALIE E. CUSANO, JOHN P. BILEZIKIAN, Osteoporosis, Clinical Obstetrics and Gynecology, 2013, 56, 4, 730

    CrossRef

  21. 21
    Marilyn Augustine, Mara J. Horwitz, Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs as Therapies for Osteoporosis, Current Osteoporosis Reports, 2013, 11, 4, 400

    CrossRef

  22. 22
    Dima L. Diab, Nelson B. Watts, Postmenopausal osteoporosis, Current Opinion in Endocrinology & Diabetes and Obesity, 2013, 20, 6, 501

    CrossRef

  23. 23
    N. E. Cusano, M. R. Rubin, D. Irani, J. Sliney, J. P. Bilezikian, Use of parathyroid hormone in hypoparathyroidism, Journal of Endocrinological Investigation, 2013, 36, 11, 1121

    CrossRef

  24. 24
    Aline Costa, Natalie E. Cusano, Barbara C. Silva, John P. Bilezikian, Osteoporosis, 2013,

    CrossRef